{"disease":{"id":"immunocompromised-host","name":"immunocompromised host"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00904579","title":"Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease","phase":"","overall_status":"COMPLETED","enrollment_count":19929901,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04043793","title":"ICU-acquired Colonization and Infection Related to MDR in Immunocompromised Patients","phase":"","overall_status":"COMPLETED","enrollment_count":759,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT06599658","title":"COVID-19 Booster and IIV Schedule in Immunocompromised Hosts","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":660,"lead_sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","has_results":false},{"nct_id":"NCT04047719","title":"Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens","phase":"","overall_status":"COMPLETED","enrollment_count":257,"lead_sponsor_name":"Karius, Inc.","has_results":false},{"nct_id":"NCT05216588","title":"Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies With Early Access Authorization in Immunocompromised Patients. A Prospective Cohort.","phase":"","overall_status":"COMPLETED","enrollment_count":149,"lead_sponsor_name":"ANRS, Emerging Infectious Diseases","has_results":false},{"nct_id":"NCT00923832","title":"Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis","phase":"","overall_status":"COMPLETED","enrollment_count":null,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}